284 related articles for article (PubMed ID: 9499500)
41. Aortic Prosthetic Valve Endocarditis: Analysis of The Society of Thoracic Surgeons Database.
Caceres Polo M; Thibault D; Jawitz OK; Zwischenberger BA; O'Brien SM; Thourani VH; Jacobs JP; Hooker RL
Ann Thorac Surg; 2022 Dec; 114(6):2140-2147. PubMed ID: 34875263
[TBL] [Abstract][Full Text] [Related]
42. Daptomycin-containing regimens for treatment of Gram-positive endocarditis.
Russo A; Peghin M; Givone F; Ingani M; Graziano E; Bassetti M
Int J Antimicrob Agents; 2019 Oct; 54(4):423-434. PubMed ID: 31400470
[TBL] [Abstract][Full Text] [Related]
43. [Surgical correction with homograft in native or prosthetic aortic valve infective endocarditis].
Gamba A; Terzi A; Ferrazzi P; Farina C; Suter F
Ital Heart J Suppl; 2002 Jul; 3(7):728-37. PubMed ID: 12187633
[TBL] [Abstract][Full Text] [Related]
44. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.
Anguera I; Del Río A; Miró JM; Matínez-Lacasa X; Marco F; Gumá JR; Quaglio G; Claramonte X; Moreno A; Mestres CA; Mauri E; Azqueta M; Benito N; García-de la María C; Almela M; Jiménez-Expósito MJ; Sued O; De Lazzari E; Gatell JM;
Heart; 2005 Feb; 91(2):e10. PubMed ID: 15657200
[TBL] [Abstract][Full Text] [Related]
45. Clinical and echocardiographic predictors of morbidity and mortality in infective endocarditis: the significance of vegetation size.
Gotsman I; Meirovitz A; Meizlish N; Gotsman M; Lotan C; Gilon D
Isr Med Assoc J; 2007 May; 9(5):365-9. PubMed ID: 17591374
[TBL] [Abstract][Full Text] [Related]
46. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004.
Yusuf SW; Ali SS; Swafford J; Durand JB; Bodey GP; Chemaly RF; Kontoyiannis DP; Tarrand J; Rolston KV; Yeh E; Raad II; Safdar A
Medicine (Baltimore); 2006 Mar; 85(2):86-94. PubMed ID: 16609347
[TBL] [Abstract][Full Text] [Related]
47. Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey.
Tuğcu A; Yildirimtürk O; Baytaroğlu C; Kurtoğlu H; Köse O; Sener M; Aytekin S
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):9-18. PubMed ID: 19225248
[TBL] [Abstract][Full Text] [Related]
48. [Treatment outcome of prosthetic valve endocarditis].
Abramczuk E; Rawczyńska-Englert I; Grabowski M; Jarnicka W
Przegl Lek; 2003; 60(9):549-52. PubMed ID: 15065330
[TBL] [Abstract][Full Text] [Related]
49. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis.
Chan KL; Dumesnil JG; Cujec B; Sanfilippo AJ; Jue J; Turek MA; Robinson TI; Moher D;
J Am Coll Cardiol; 2003 Sep; 42(5):775-80. PubMed ID: 12957419
[TBL] [Abstract][Full Text] [Related]
50. [A case of infective endocarditis with multiple embolic complications].
Sakata K; Misawa Y; Kato M; Take A; Takahashi T; Hasegawa T
Nihon Kyobu Geka Gakkai Zasshi; 1992 Sep; 40(9):1759-63. PubMed ID: 1402196
[TBL] [Abstract][Full Text] [Related]
51. Long-term prognosis of left-sided native-valve Staphylococcus aureus endocarditis.
Abdallah L; Remadi JP; Habib G; Salaun E; Casalta JP; Tribouilloy C
Arch Cardiovasc Dis; 2016 Apr; 109(4):260-7. PubMed ID: 26898635
[TBL] [Abstract][Full Text] [Related]
52. Methicillin resistance and risk factors for embolism in Staphylococcus aureus infective endocarditis.
Hsu RB; Lin FY
Infect Control Hosp Epidemiol; 2007 Jul; 28(7):860-6. PubMed ID: 17564990
[TBL] [Abstract][Full Text] [Related]
53. Asymptomatic and symptomatic embolic events in infective endocarditis: associated factors and clinical impact.
Monteiro TS; Correia MG; Golebiovski WF; Barbosa GIF; Weksler C; Lamas CC
Braz J Infect Dis; 2017; 21(3):240-247. PubMed ID: 28263711
[TBL] [Abstract][Full Text] [Related]
54. Comparative Surgical Outcomes of Prosthetic and Native Valve Endocarditis.
Pyo WK; Kim HJ; Kim JB; Jung SH; Choo SJ; Chung CH; Lee JW
Korean Circ J; 2021 Jun; 51(6):504-514. PubMed ID: 34085423
[TBL] [Abstract][Full Text] [Related]
55. Infective endocarditis: a retrospective cohort study.
O'Connor CT; O'Rourke S; Buckley A; Murphy R; Crean P; Foley B; Maree A; Ryan R; Tolan M; Young V; O'Connell B; Daly C
QJM; 2019 Sep; 112(9):663-667. PubMed ID: 31147713
[TBL] [Abstract][Full Text] [Related]
56. Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device-Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017.
Khaloo P; Uzomah UA; Shaqdan A; Ledesma PA; Galvin J; Ptaszek LM; Ruskin JN
J Am Heart Assoc; 2022 Sep; 11(17):e025600. PubMed ID: 36000421
[TBL] [Abstract][Full Text] [Related]
57. The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events.
Kupferwasser LI; Hafner G; Mohr-Kahaly S; Erbel R; Meyer J; Darius H
J Am Coll Cardiol; 1999 Apr; 33(5):1365-71. PubMed ID: 10193740
[TBL] [Abstract][Full Text] [Related]
58. Impact of early surgery on embolic events in patients with infective endocarditis.
Kim DH; Kang DH; Lee MZ; Yun SC; Kim YJ; Song JM; Song JK; Lee JW; Sohn DW
Circulation; 2010 Sep; 122(11 Suppl):S17-22. PubMed ID: 20837909
[TBL] [Abstract][Full Text] [Related]
59. Active infective endocarditis: low mortality associated with early surgical treatment.
Perić M; Vuk F; Huskić R; Lausević-Vuk L; Nesković AN; Borzanović M; Bojić M
Cardiovasc Surg; 2000 Apr; 8(3):208-13. PubMed ID: 10799830
[TBL] [Abstract][Full Text] [Related]
60. Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study.
Chu VH; Miro JM; Hoen B; Cabell CH; Pappas PA; Jones P; Stryjewski ME; Anguera I; Braun S; Muñoz P; Commerford P; Tornos P; Francis J; Oyonarte M; Selton-Suty C; Morris AJ; Habib G; Almirante B; Sexton DJ; Corey GR; Fowler VG;
Heart; 2009 Apr; 95(7):570-6. PubMed ID: 18952633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
